Abstract:Histone modifications, including lysine methylation, are epigenetic marks that influence many biological pathways. Accordingly, many methyltransferases have critical roles in various biological processes, and their dysregulation is often associated with cancer. However, the biological functions and regulation of many methyltransferases are unclear. Here, we report that a human homolog of the methyltransferase SET (SU(var), enhancer of zeste, and trithorax) domain containing 3 (SETD3) is cell cycle-regulated; SETD3 protein levels peaked in S phase and were lowest in M phase. We found that the β-isoform of the tumor suppressor F-box and WD repeat domain containing 7 (FBXW7β) specifically mediates SETD3 degradation. Aligning the SETD3 sequence with those of well known FBXW7 substrates, we identified six potential non-canonical Cdc4 phosphodegrons (CPDs), and one of them, CPD1, is primarily phosphorylated by the kinase glycogen synthase kinase 3 (GSK3β), which is required for FBXW7β-mediated recognition and degradation. Moreover, depletion or inhibition of GSK3β or FBXW7β resulted in elevated SETD3 levels. Mutations of the phosphorylated residues in CPD1 of SETD3 abolished the interaction between FBXW7β and SETD3 and prevented SETD3 degradation. Our data further indicated that SETD3 levels positively correlated with cell proliferation of liver cancer cells and liver tumorigenesis in a xenograft mouse model, and that overexpression of FBXW7β counteracts the SETD3's tumorigenic role. We also show that SETD3 levels correlate with cancer malignancy, indicated by SETD3 levels that the 54 liver tumors are 2-fold higher than those in the relevant adjacent tissues. Collectively, these data elucidated that a GSK3β-FBXW7β-dependent mechanism controls SETD3 protein levels during the cell cycle and attenuates its oncogenic role in liver tumorigenesis.

SETD3 functions beyond histidine methylation

Setd2, A H3k36 Lysine Methyltransferase, is Essential for Adult Normal Hematopoiesis and Leukemia Stem Cells

Structural Insights Into Setd3-Mediated Histidine Methylation On Beta-Actin

Setd2 Regulates Quiescence and Differentiation of Adult Hematopoietic Stem Cells by Restricting RNA Polymerase II Elongation.

Substrate Specificity for Human Histidine Methyltransferase SETD3

Histidine Methyltransferase SETD3 Methylates Structurally Diverse Histidine Mimics in Actin

SETD3-mediated Histidine Methylation of MCM7 Regulates DNA Replication by Facilitating Chromatin Loading of MCM

The methyltransferase SETD3 regulates mRNA alternative splicing through interacting with hnRNPK

Molecular Basis for Oncohistone H3 Recognition by SETD2 Methyltransferase

Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton

SETDB1 activity is globally directed by H3K14 acetylation via its Triple Tudor Domain

The role of SET domain containing lysine methyltransferase 7 in tumorigenesis and development

H3K36 trimethylation-mediated biological functions in cancer

SET Domain Proteins in Plants

Cryo-EM Structure of SETD2/Set2 Methyltransferase Bound to a Nucleosome Containing Oncohistone Mutations

Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic Transcription

Molecular Insight into the SETD1A/B N-terminal Region and Its Interaction with WDR82

Cell Cycle-Dependent Degradation of the Methyltransferase SETD3 Attenuates Cell Proliferation and Liver Tumorigenesis

SETD3 is a positive regulator of DNA-damage-induced apoptosis

SETD3 is Regulated by a Couple of Micrornas and Plays Opposing Roles in Proliferation and Metastasis of Hepatocellular Carcinoma.

Structural basis of H3K36 trimethylation by SETD2 during chromatin transcription